Copanlisib Hydrochloride

 (koh-PAN-lih-sib HY-droh-KLOR-ide)

This page contains brief information about copanlisib hydrochloride and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
FDA Approved

FDA label information for this drug is available at DailyMed.

Use in Cancer

Copanlisib hydrochloride is approved to treat:

Copanlisib hydrochloride is also being studied in the treatment of other types of cancer.

More About Copanlisib Hydrochloride

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

Copanlisib Approved for Follicular Lymphoma

Targeted Cancer Therapies

Clinical Trials Accepting Patients

Find Clinical Trials for Copanlisib Hydrochloride - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted: September 25, 2017
  • Updated: October 18, 2018